ASND Ascendis Pharma A/S
Healthcare$247.05-0.19%ClosedMarket Cap: $15.26B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$287.50
Target (Median)
$267.50
Target Range
$250.00 - $345.00
Upside from current price: 16.4%
Rating Distribution
4 Strong Buy13 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-15 | Evercore ISI Group | maintain | Outperform | Outperform |
| 2026-05-11 | Barclays | maintain | Overweight | Overweight |
| 2026-05-08 | Wells Fargo | maintain | Overweight | Overweight |
| 2026-04-16 | B of A Securities | maintain | Buy | Buy |
| 2026-04-09 | Wedbush | maintain | Outperform | Outperform |
| 2026-03-03 | RBC Capital | maintain | Outperform | Outperform |
| 2026-02-12 | Wedbush | maintain | Outperform | Outperform |
| 2026-02-12 | Oppenheimer | maintain | Outperform | Outperform |
| 2026-01-30 | B of A Securities | maintain | Buy | Buy |
| 2026-01-20 | RBC Capital | maintain | Outperform | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $9.46 | $1.96B | 11 |
| Sun Dec 31 | $14.58 | $2.44B | 9 |
| Mon Dec 31 | $18.04 | $3.02B | 3 |
| Tue Dec 31 | $20.68 | $3.37B | 3 |